Vitamin D receptor gene polymorphism was determined in 66 and 60 Japanese p
atients with prostate cancer and non cancer controls, respectively. In cont
rast to previous reports showing an association between vitamin D receptor
polymorphism of a TaqI restriction fragment length polymorphism at codon 35
2 (genotype tt) and prostate cancer in an American population, the frequenc
y of genotype tt is less than one percent in the Japanese population. There
was no difference between the patients and the controls in the vitamin D r
eceptor TaqI genotype. In patients with metastatic prostate cancer, genotyp
e TT had a tendency to shorter progression free survival compared to genoty
pe Tt, but the number of patients was limited.